At the time of writing, Moelis & Co [MC] stock is trading at $66.82, up 6.42%. An important factor to consider is whether the stock is rising or falling in short-term value. The MC shares have gain 2.66% over the last week, with a monthly amount glided 26.46%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Moelis & Co [NYSE: MC] stock has seen the most recent analyst activity on March 13, 2024, when Goldman upgraded its rating to a Neutral and also boosted its price target to $58 from $53. On January 11, 2023, downgrade downgraded it’s rating to Sell and revised its price target to $37 on the stock. Keefe Bruyette downgraded its rating to a Underperform and decreased its price target to $37 on November 03, 2022. UBS downgraded its rating to a Sell and reduced its price target to $35 on September 23, 2022. Morgan Stanley downgraded its rating to Underweight for this stock on July 18, 2022, and downed its price target to $36. In a note dated July 11, 2022, Wolfe Research downgraded an Underperform rating on this stock but restated the target price of $42.
For the past year, the stock price of Moelis & Co fluctuated between $38.58 and $68.50. Currently, Wall Street analysts expect the stock to reach $44.33 within the next 12 months. Moelis & Co [NYSE: MC] shares were valued at $66.82 at the most recent close of the market. An investor can expect a potential drop of -33.66% based on the average MC price forecast.
Analyzing the MC fundamentals
According to Moelis & Co [NYSE:MC], the company’s sales were 969.13M for trailing twelve months, which represents an 47.10% jump. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -0.0%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.04 and Total Capital is -0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 63.51 points at the first support level, and at 60.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.94, and for the 2nd resistance point, it is at 71.06.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 4.85, the price to book ratio is 12.90 and price to earnings (TTM) ratio is 438.74.
Transactions by insiders
Recent insider trading involved MAHMOODZADEGAN NAVID, Co-President, MD, that happened on May 13 ’24 when 44980.0 shares were sold. Chairman, CEO, MOELIS KENNETH completed a deal on May 10 ’24 to sell 37102.0 shares. Meanwhile, Chairman, CEO MOELIS KENNETH sold 40000.0 shares on May 09 ’24.
